Efficacy and Safety of Diclofenac Suppository for Post-operative Pain Relief After Diagnostic Hystero-laparoscopy and Dye Test: A Double-blind Placebo Controlled Randomised Study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202102546768103

Enrollment

108

Registered

2021-02-18

Start date

2020-12-03

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female

Interventions

Diclofenac arm

Placebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Women scheduled for dHLD for infertility at gynaecology clinic of NAUTH and outpatient department of LIFE. 2. Consenting women planned for dHLD without additional procedures. 3. Women between the age of 18 and 45 years.

Exclusion criteria

Exclusion criteria: Those women known to have reacted to NSAIDs in the past, those with renal disease/impairment, known asthmatics, gastric or duodenal ulcer and inability to rate pain using visual analogue scale (VAS)

Design outcomes

Primary

Measure	Time frame
The primary outcome measures will include pain scores at 4th postoperative hour and 2-hourly subsequently up to the 12th postoperative hour using VAS.	—

Secondary

Measure	Time frame
The secondary outcome measures will include analgesic requirement, time point when request for first additional analgesic was made, proportion of women requiring additional analgesic agent, patients’ satisfaction, and any adverse event.	—

Countries

Nigeria

Contacts

Public ContactGeorge Eleje

Senior Lecturer

gu.eleje@unizik.edu.ng+2348068117444

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026